Philips
(NYSE: PHG)
announced today that it made major enhancements to its Azurion image-guided therapy system with a new launch.
The Amsterdam-based medtech giant unveiled its new Azurion neuro biplane system at ECR 2024. It designed the system to streamline neurovascular procedures and help care teams make the right decisions and do so faster. This enables the treatment of more patients and better outcomes.
Philips’ new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. The company believes it enhances both the staff and patient experience and contributes to lower costs for care.
Azurion smooths and optimizes procedure workflows for confident diagnosis and precision treatment. It utilizes the company’s latest Neuro Suite software and services to provide a fully integrated solution. New features include enhanced C-arm rotation, angulation and parking facilities for rapid transitioning between 2D and 3D imaging. It has comprehensive tableside control to eliminate the need to leave the sterile field as well.
Philips added automatic beam rotation to obtain correctly oriented images for every angulation and rotation, too. Azurion’s new head immobilizer to support enhanced stroke care as well. Philips also set out to maximize the up-time of its angio suite solutions with AI and machine learning to monitor system performance. It now remotely connects its services with the Philips ServiceHub to communicate, monitor and proactively respond to potential service issues.
“Working closely with leading interventionists, we designed the latest Azurion neuro biplane to meet their requirements of superior patient care, optimized angio suite performance, and efficient return on investment,” said Mark Stoffels, Philips business leader of Image Guided Therapy Systems. “Together, I am confident we can continue to reduce the impact of stroke, helping more patients to recover faster and reducing long-term impact on their health.”